Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Haplotype-based approach for noninvasive prenatal diagnosis of congenital adrenal hyperplasia by maternal plasma DNA sequencing.
[congenital adrenal hyperplasia]
Prenatal
diagnosis
of
congenital
adrenal
hyperplasia
(
CAH
)
is
of
clinical
significance
because
in
utero
treatment
is
available
to
prevent
virilization
of
an
affected
female
fetus
.
However
,
traditional
prenatal
diagnosis
of
CAH
relies
on
genetic
testing
of
fetal
genomic
DNA
obtained
using
amniocentesis
or
chorionic
villus
sampling
,
which
is
associated
with
an
increased
risk
of
miscarriage
.
The
aim
of
this
study
was
to
demonstrate
the
feasibility
of
a
new
haplotype-based
approach
for
the
noninvasive
prenatal
testing
of
CAH
due
to
21
-
hydroxylase
deficiency
.
Parental
haplotypes
were
constructed
using
target-region
sequencing
data
of
the
parents
and
the
proband
.
With
the
assistance
of
the
parental
haplotypes
,
we
recovered
fetal
haplotypes
using
a
hidden
Markov
model
(
HMM
)
through
maternal
plasma
DNA
sequencing
.
In
the
genomic
region
around
the
CYP
21
A
2
gene
,
the
fetus
inherited
the
paternal
haplotype
'
0
'
alleles
linked
to
the
mutant
CYP
21
A
2
gene
,
but
the
maternal
haplotype
'
1
'
alleles
linked
to
the
wild-
type
gene
.
The
fetus
was
predicted
to
be
an
unaffected
carrier
of
CAH
,
which
was
confirmed
by
genetic
analysis
of
fetal
genomic
DNA
from
amniotic
fluid
cells
.
This
method
was
further
validated
by
comparing
the
inferred
SNP
genotypes
with
the
direct
sequencing
data
of
fetal
genomic
DNA
.
The
result
showed
an
accuracy
of
96
.
41
%
for
the
inferred
maternal
alleles
and
an
accuracy
of
97
.
81
%
for
the
inferred
paternal
alleles
.
The
haplotype-based
approach
is
feasible
for
noninvasive
prenatal
testing
of
CAH
.
Diseases
Validation
Diseases presenting
"increased risk of miscarriage. the aim of this study"
symptom
congenital adrenal hyperplasia
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom